| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $286K | — | -45.8% |
| Cost of Revenue | $208K | — | +55.7% |
| Gross Profit | $78K | — | -80.2% |
| R&D Expense | $15K | -77.5% | -84.3% |
| SG&A Expense | $727K | +127.2% | +31.2% |
| Operating Income | -$2.2M | — | -139.1% |
| Interest Expense | $6K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $804K | +28.7% | — |
| Accounts Receivable | $271K | — | +873.5% |
| Inventory | $128K | — | -87.0% |
| Current Assets | $9.8M | +33.8% | +18.8% |
| Total Assets | $14.9M | +59.3% | +33.3% |
| Current Liabilities | $5.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.2M | — | — |
| Capital Expenditures | $96K | — | — |
| Investing Cash Flow | -$2.2M | — | — |
| Financing Cash Flow | $10.1M | — | — |
| Free Cash Flow | -$4.3M | — | — |
| — |
| Net Income | -$2.6M | -361.3% | -72.8% |
| +1573.8% |
| +156.4% |
| Total Liabilities | $6.4M | +1875.9% | +143.3% |
| Stockholders' Equity | $8.5M | -6.2% | -0.8% |